Update from the PBAC (April 2026)

7 May 2026 - The PBAC has published its April 2026 update. ...

Read more →

Update to agenda for the July 2026 PBAC meeting (8 May 2026)

8 May 2026 - The agenda for the July 2026 PBAC meeting has now been updated. ...

Read more →

Expert says treatment relieves children's suffering and saves hospital resources

5 May 2026 - The family of an eight year old Sunshine Coast girl is petitioning the federal government to ...

Read more →

'Tearing her skin apart': Sydney family among thousands priced out of life-changing medication

3 May 2026 - Jade Hlucshniow was on the brink of selling her home to afford treatment for her daughter, ...

Read more →

Affordable treatment for Australians with colorectal cancer

3 May 2026 - Australians with stage 4 colorectal cancer are among those who will benefit from new drug listings ...

Read more →

Agenda for the May 2026 PBAC meeting

1 May 2026 - The agenda for the May 2026 PBAC meeting is now available. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 May 2026

1 May 2026 - The May 2026 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Have your say on the framework for consumer engagement in HTA

29 April 2026 - We are developing a framework that sets out guiding principles, focus areas and actions to support ...

Read more →

Draft 2026-27 Cost Recovery Implementation Statement for listing medicines on the PBS and designated vaccines on the NIP

30 April 2026 - Consultation on the draft 2026-27 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical ...

Read more →

Broken PBS system behind failure to list Mounjaro for type 2 diabetics, according to Medicines Australia

28 April 2026 - Hundreds of thousands of Australians with diabetes will continue paying thousands of dollars a year for ...

Read more →

Price feud over Mounjaro denies Australians access to cheaper diabetes and weight loss drug

24 April 2026 - Hundreds of thousands of Australians with type 2 diabetes mellitus could miss out on access to ...

Read more →

Calls for $1 million gel to be available in Oz to fight rare genetic disease

26 April 2026 - A little boy suffering a rare disease that leaves the skin as delicate as butterfly wings ...

Read more →

‘Unviable’: 450,000 Australians to miss out on subsidised weight loss drug

24 April 2026 - An estimated 450,000 Australians will miss out on discounted weight loss medication after pharmaceutical giant Eli ...

Read more →

Drug company Lilly refuses to list Mounjaro on PBS, says price too low

24 April 2026 - Drug company Eli Lilly has refused to place Mounjaro on the PBS despite the regulator recommending ...

Read more →

‘Diffficult to see’ Mounjaro funded for weight loss, says pharma as diabetes stoush erupts

25 April 2026 - The weight loss drug has finally been recommended for public funding for those with diabetes, but manufacturers ...

Read more →